David B. Roberts - 11 Dec 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
President and Director, Director
Signature
/s/ David C. Hissong
Issuer symbol
LMAT
Transactions as of
11 Dec 2023
Net transactions value
-$31,813
Form type
4
Filing time
13 Dec 2023, 17:11:13 UTC
Previous filing
12 Dec 2023
Next filing
21 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +14 +0.1% $0.000000 13,392 11 Dec 2023 Direct F1
transaction LMAT Common Stock Tax liability $15,885 -292 -2.2% $54.40 13,100 11 Dec 2023 Direct F2
transaction LMAT Common Stock Options Exercise $0 +6 +0.05% $0.000000 13,106 12 Dec 2023 Direct F1
transaction LMAT Common Stock Tax liability $15,928 -296 -2.3% $53.81 12,810 12 Dec 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -14 -33% $0.000000 29 11 Dec 2023 Common Stock 14 Direct F4
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -6 -22% $0.000000 21 12 Dec 2023 Common Stock 6 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F4 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.